New single domain antibody dropping july 3 - excited to share our work using display technologies to develop novel biologics that allosterically inhibit enpp1 (led by the fearless and twitterless Paige Solomon)
A new paper from @realJimWells generated variable heavy single-domain antibodies that bind and allosterically inhibit ENNP1 1 to increase the half-life of the immune-stimulant cGAMP in tumor microenvironments. Open access.View quoted post on X